"Next Generation DNA Sequencing (NGS) Market - Size, Share, Industry Trends, Demand and Opportunities
Global Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) – Industry Trends and Forecast to 2029.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-next-generation-dna-sequencing-ngs-market
**Segments**
- Based on product & service, the global next generation DNA sequencing (NGS) market can be segmented into reagents & consumables, sequencing services, sequencing platforms, and software.
- On the basis of application, the market can be categorized into oncology, reproductive health, clinical investigation, agrigenomics & forensic, and others.
- By technology, the segments include sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, Nanopore sequencing, and others.
- Geographically, the market is divided into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
**Market Players**
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Pacific Biosciences of California, Inc.
- Qiagen
- Agilent Technologies, Inc.
- BGI
- Eurofins Scientific
- Macrogen, Inc.
- Oxford Nanopore Technologies
- Myriad Genetics, Inc.
- PerkinElmer Inc.
The global next generation DNA sequencing (NGS) market is poised for significant growth due to the rising adoption of personalized medicine, increasing applications in clinical diagnostics, and advancements in sequencing technologies. The reagents & consumables segment is expected to dominate the market, driven by the continuous need for these products in sequencing procedures. Within the application segment, oncology is projected to witness substantial growth with the growing prevalence of cancer worldwide and the demand for precision medicine. Among the technology segments, sequencing by synthesis (SBS) holds a significant market share owing to its accuracy and efficiency in DNA sequencing.
North America is anticipated to lead the global NGS market, attributed to the presence of key market players, technological advancements, and a high adoption rate of NGS technologies in the region's healthcare facilities. Europe follows closely behind, supported by increasing research activities and government initiatives in genomics. The Asia-Pacific region is expected to experience rapid growth due to the expanding healthcare infrastructure, growing awareness about personalized medicine, and increasing investments in genomics research.
In terms of market players, Illumina, Inc. and Thermo Fisher Scientific Inc. are among the top contenders, leveraging their strong market presence, diversified product portfolios, and strategic collaborations to maintain their positions. Other key players such as Qiagen, Pacific Biosciences of California, Inc., and Agilent Technologies, Inc. are also making significant contributions to the market through product innovations and strategic partnerships. Overall, the global NGS market is poised for substantial growth in the coming years, driven by technological advancements, expanding applications, and the increasing focus on precision medicine.
https://www.databridgemarketresearch.com/reports/global-next-generation-dna-sequencing-ngs-marketThe global next-generation DNA sequencing (NGS) market is witnessing significant growth driven by various factors such as the increasing focus on personalized medicine, advancements in sequencing technologies, and expanding applications across different sectors. As the demand for precision medicine continues to rise, the NGS market is expected to further accelerate, with a particular focus on applications in oncology, reproductive health, clinical investigation, agrigenomics & forensic, and other emerging areas. The market segmentation based on product & service, application, technology, and geography provides a comprehensive overview of the diverse factors influencing the market dynamics.
In terms of product & service segmentation, the reagents & consumables segment is projected to lead the market, driven by the continuous demand for these essential components in sequencing procedures. The sequencing services segment is also expected to witness steady growth as more organizations and research institutions outsource their sequencing requirements. Furthermore, the sequencing platforms and software segments are crucial components contributing to the overall efficiency and accuracy of NGS processes.
From an application standpoint, the oncology segment is poised for substantial growth due to the increasing prevalence of cancer globally and the escalating need for tailored treatment options. The advancements in NGS technologies have revolutionized oncology diagnostics and therapeutic strategies, leading to a paradigm shift in cancer care. Similarly, other application areas such as reproductive health, clinical investigation, agrigenomics & forensic are also driving market growth by leveraging the capabilities of NGS in diverse fields.
The technology segmentation highlights the various sequencing techniques that are shaping the NGS market landscape. Sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, Nanopore sequencing, and other emerging technologies are driving innovation and enhancing the efficiency of DNA sequencing processes. These technologies play a pivotal role in enabling researchers and clinicians to explore the complexities of the genome and decipher key genetic information for diverse applications.
Geographically, North America is expected to maintain its dominance in the global NGS market, primarily driven by the presence of key market players, advanced healthcare infrastructure, and robust research and development activities. Europe and the Asia-Pacific regions are also significant contributors to the market growth, with Europe witnessing increasing research initiatives in genomics and the Asia-Pacific region experiencing rapid adoption of NGS technologies in healthcare settings.
Overall, the global NGS market is characterized by intense competition, technological innovation, and strategic collaborations among key players. Companies such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, and others are at the forefront of driving market expansion through product development and strategic partnerships. As the market continues to evolve, the focus on precision medicine, personalized healthcare, and expanding applications of NGS technologies are expected to fuel further growth and innovation in the coming years, shaping the future of genomic research and diagnostics.**Segments:**
- Product & Service: The global next-generation DNA sequencing market is segmented into reagents & consumables, sequencing services, sequencing platforms, and software. The reagents & consumables segment is expected to dominate the market due to the continuous need for these products in sequencing procedures. Sequencing services are witnessing steady growth as more organizations outsource their sequencing requirements. The sequencing platforms and software segments play a crucial role in enhancing the efficiency and accuracy of NGS processes.
- Application: The market can be categorized into oncology, reproductive health, clinical investigation, agrigenomics & forensic, and others. The oncology segment is projected to witness significant growth with the rising prevalence of cancer globally and the demand for precision medicine. Other application areas are also driving market growth by leveraging NGS capabilities in diverse fields.
- Technology: Technology segments include sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, Nanopore sequencing, and others. These sequencing techniques are driving innovation and enhancing the efficiency of DNA sequencing processes, enabling researchers and clinicians to explore the complexities of the genome for various applications.
- Geography: Geographically, the market is divided into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America is expected to lead the global NGS market, followed by Europe and the Asia-Pacific region due to factors such as advanced healthcare infrastructure, research initiatives, and increasing adoption of NGS technologies.
Global Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) – Industry Trends and Forecast to 2029.
The global next-generation DNA sequencing market is witnessing significant growth driven by the increasing focus on personalized medicine, advancements in sequencing technologies, and expanding applications across different sectors. The rising demand for precision medicine is expected to further accelerate the NGS market, with a particular emphasis on applications in oncology, reproductive health, clinical investigation, agrigenomics & forensic, and other emerging areas. The market segmentation provides a comprehensive overview of the diverse factors influencing market dynamics.
In terms of product & service segmentation, the reagents & consumables segment is projected to lead the market, driven by the continuous demand for essential components in sequencing procedures. Sequencing services and platforms/software segments are also vital components contributing to the efficiency and accuracy of NGS processes. The oncology segment is poised for substantial growth, revolutionizing diagnostics and therapeutic strategies. Other application areas such as reproductive health and agrigenomics & forensic are also driving market growth by leveraging NGS capabilities.
Technological advancements play a pivotal role in shaping the NGS market landscape, with sequencing techniques like SBS, ion semiconductor sequencing, SMRT sequencing, Nanopore sequencing, and other emerging technologies enhancing the efficiency of DNA sequencing processes. Geographically, North America, Europe, and the Asia-Pacific regions are key players in the global NGS market, with North America leading due to the presence of market players and advanced healthcare infrastructure. Companies like Illumina, Thermo Fisher Scientific, and Qiagen are driving market expansion through product development and partnerships, fueling further growth and innovation in genomic research and diagnostics.
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Next Generation DNA Sequencing (NGS) Market Landscape
Part 04: Global Next Generation DNA Sequencing (NGS) Market Sizing
Part 05: Global Next Generation DNA Sequencing (NGS) Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Next Generation DNA Sequencing (NGS) Key Benefits over Global Competitors:
- The report provides a qualitative and quantitative analysis of the Next Generation DNA Sequencing (NGS) Market trends, forecasts, and market size to determine new opportunities.
- Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
- Top impacting factors & major investment pockets are highlighted in the research.
- The major countries in each region are analyzed and their revenue contribution is mentioned.
- The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients
Browse Trending Reports:
Blood Bags Market Size, Share and Trends
Portable Immunoassay Analyzer Market Size, Share and Trends
Biological Buffers Market Size, Share and Trends
Remdesivir Market Size, Share and Trends
Quick Service Restaurants and Fast Food Market Size, Share and Trends
Communication Air Traffic Control Equipment Market Size, Share and Trends
Aircraft Antenna Market Size, Share and Trends
Lattice and Telescopic Boom Market Size, Share and Trends
Gusset Seal Market Size, Share and Trends
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Comments
0 comment